Significant Ownership of JOHNSON & JOHNSON

Signature - Title: /s/ Marc Larkins - Mark Larkins/Secretary
Location: New Brunswick, NJ
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by JOHNSON & JOHNSON.

Notify me when JOHNSON & JOHNSON files a new Schedule 13D/G report.

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
RAPP	Rapport Therapeutics, Inc.	Common Stock, $0.001 par value	4.9%	$53,000,690		1,784,517		JOHNSON & JOHNSON	30 Sep 2025

Schedules 13D/G Reported by JOHNSON & JOHNSON:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Filing Date

* An asterisk sign (*) next to the price indicates that the price is likely invalid.